Jacqueline R. Kelly, MD, MSc

Articles by Jacqueline R. Kelly, MD, MSc

Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy and Oxaliplatin-Induced Fever Associated With IL-6 Release in a Patient With Locally Advanced Colon Cancer

ByMehmet Sitki Copur, MD, FACP,Caleb W. Schroeder, MD,Quan Ly, MD,Whitney Wedel, MD,Jacqueline R. Kelly, MD, MSc,Paul Rodriguez, MD,Soe Min Tun, MD, MBA, MSc,Nicholas Lintel, MD,Adam J. Horn, MD,Bronson Riley, CGC

February 15th 2022

This case presents a patient with locally advanced, unresectable, mismatch repair–deficient sigmoid colon cancer who was treated with neoadjuvant chemoimmunotherapy followed by surgical resection leading to a complete pathologic response after preoperative systemic chemoimmunotherapy.

A 64-Year-Old Man With Germline BRCA2-Mutated Breast Cancer: Known and Unknown Aspects of Male Breast Cancer

ByMehmet Sitki Copur, MD, FACP,Jacqueline R. Kelly, MD, MSc,Nicholas Lintel, MD,Bronson Riley, MS,Daniel J. Herold, MD,Shellie Faris, MD,Whitney Wedel, MD,Adam J. Horn, MD

August 13th 2021

This study presents a male breast cancer case with a germline BRCA2 mutation and discusses the epidemiologic, pathologic, and clinical characteristics along with treatment and follow-up recommendations in view of our recent understanding of the disease.

Chemoradiation Therapy vs Surgery in HPV-Positive Head and Neck Cancer

ByJacqueline R. Kelly, MD, MSc

November 8th 2017

In this interview we discuss a retrospective study that looked at survival outcomes in HPV-positive oropharyngeal cancer patients treated with either definitive chemoradiation therapy or primary surgery.

Accelerated Partial Breast Irradiation for Breast Cancer: Not Ready for Routine Use

ByJacqueline R. Kelly, MD, MSc,Suzanne Evans, MD, MPH

February 15th 2017

We know that breast cancer represents a spectrum of diseases, with variation in prognosis, and that RT can range from highly complex treatments to the breast and regional lymph nodes, to complete avoidance of radiation.